Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms

Details for Australian Patent Application No. 2010313228 (hide)

Owner Biogenic Innovations, LLC

Inventors Benjamin, Rodney; Varelman, Jeffrey; Keller, Anthony

Agent Fisher Adams Kelly

Pub. Number AU-A-2010313228

PCT Pub. Number WO2011/053848

Priority 61/256,935 30.10.09 US; 61/257,751 03.11.09 US; 61/294,437 12.01.10 US; 61/259,098 06.11.09 US

Filing date 29 October 2010

Wipo publication date 5 May 2011

International Classifications

A61K 31/10 (2006.01)

A61K 31/437 (2006.01)

A61K 39/085 (2006.01) Medicinal preparations containing antigens or antibodies - Staphylococcus

Event Publications

14 June 2012 PCT application entered the National Phase

  PCT publication WO2011/053848 Priority application(s): WO2011/053848

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010313232-GNA11 mutations in melanoma

2010313219-Self-drilling fastener